A latest statistical data titled as Global Pre-Owned Medical Devices Market has been published by Research N Reports. The report covers penetrative insights into distinctive market features such as recent trends which are comprehensively discussed in order to provide an in-depth analysis of the progress of the industries. Effective exploratory techniques such as qualitative and quantitative analysis are used in order to explore accurate data. Porter’s five analysis and SWOT analysis have been used to examine the strength, weaknesses, threats and opportunities.
Request to Get the PDF Sample of the Report: https://www.researchnreports.com/request_sample.php?id=793246
Our industry professionals are working relentlessly to understand, assemble and timely deliver assessment on impact of COVID-19 disaster on many corporations and their clients to help them in taking excellent business decisions.
SWOT and Porter’s Five analysis are also effectively discussed to analyse informative data such as cost, prices, revenue, and end-users. The research report has been evaluated on the basis of various attributes such as manufacturing base, products or services and raw material to understand the requirements of the businesses. The Market structure covers the value chain, player categories, product ranges, key players’ presence across products and end user segments of the market. The report also provides a snapshot of key competition, market trends with forecast years, anticipated growth rates and the principal factors driving and impacting growth market data and analytics are derived from a combination of primary and secondary sources.
Furthermore, it also offers a holistic snapshot of the Global Pre-Owned Medical Devices business sector. To understand the global Pre-Owned Medical Devices market clearly different verticals are examined. In addition, the market study is supported by significant economic facts with regards to pricing structures, profit margin, and market shares. To present the data accurately, the study also makes use of effective graphical presentation techniques such as tables, charts, graphs, and pictures. The report further also highlights recent trends, tools and technology platforms that are contribute to enhance the performance of the companies.
Major Market Players Profiled in the Global Pre-Owned Medical Devices Market Report are:
- General Electric Company
- Siemens AG
- Toshiba Medical Systems Corporation
- AGITO MEDICAL A/S
- Soma Technology
- Koninklijke Philips N.V.
- Philips and many more.
Global Pre-Owned Medical Devices Market segmentation by Type:
- Type 1
- Type 2
- Type 3
Global Pre-Owned Medical Devices Market segmentation by Application:
- Application 1
- Application 2
- Application 3
Global Pre-Owned Medical Devices Market report is a believable source for gaining the market research that will exponentially accelerate your business. Additionally, it Presents new task SWOT examination, speculation attainability investigation, and venture return investigation. The report studies the Global Pre-Owned Medical Devices details and offers a granular analysis of the different factors promoting or hindering the market’s growth. It leverages market-leading explanatory instruments to gage the openings anticipating players. It moreover profiles the driving companies working in that and captures information on their incomes. Their item offerings are figured in to decide the advertise division.
Ask for Discount on the Report: https://www.researchnreports.com/ask_for_discount.php?id=793246
Key questions answered in Pre-Owned Medical Devices Market Report:
- What will the market size be in 2028 and what will the growth rate be?
- What are the key market trends?
- What is key factor driving this market?
- What are the challenges to market growth?
- Who are the major key vendors in this market space?
- What are the market opportunities, market risk and market overview and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Global Pre-Owned Medical Devices Market Report Summary:
The report covers a wide run of ranges for way better experiences of the worldwide market and industry trends and forecasts. The report covers market patterns based on product types, application regions and key vendors. Market affecting variables such as drivers, controls and venture openings has been carefully detailed in this report. The examination of the market patterns, examination and figure has been done both at the large scale and micro level viewpoint. It further gives a total thought of the strategies received by major competitors within the business. Other significant variables, which works at the regional and worldwide level to affect the market trends has been included. These impacting variables are socio-political situation, environmental conditions, demography, legal organizations, and competitive environment of the region.
Impact of COVID-19:
The Pre-Owned Medical Devices Market report includes overview, which deciphers value chain structure, industrial environment, regional examination, applications, market size and forecast. Usually a most recent report, covering the current COVID-19 effect on the market. The pandemic of Coronavirus (COVID-19) has influenced each viewpoint of life all inclusive. This has brought along a few changes in market conditions. The quickly changing market situation and initial and future evaluation of the affect is secured within the report. The report gives an overall analysis of the market based on types, applications, regions, and for the forecast period from 2020 to 2028. It moreover offers investment opportunities and likely threats within the market based on a brilliantly investigation.
The years considered to estimate the market size in this study are as follows:
- History Year: 2015-2018
- Base Year: 2020
- Forecast Year 2020 to 2028
Enquiry before Buying this premium Report: https://www.researchnreports.com/enquiry_before_buying.php?id=793246
Table of Contents:
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered
2.1 Pre-Owned Medical Devices Market Size
2.2 Pre-Owned Medical Devices Growth Trends by Regions
2.3 Industry Trends
3.1 Pre-Owned Medical Devices Market Size by Manufacturers
3.2 Pre-Owned Medical Devices Market Key Players Head office and Area Served
3.3 Key Players Pre-Owned Medical Devices Product/Solution/Service
3.4 Mergers & Acquisitions, Expansion Plans
4.1 Pre-Owned Medical Devices Sales by Product
4.2 Pre-Owned Medical Devices Revenue by Product
4.3 Pre-Owned Medical Devices Price by Product
5.2 Pre-Owned Medical Devices Market Breakdown Data by End User
Note: If you have any special requirement, please let us know and we will offer you the report as you want.
Research N Reports is a new age market research firm where we focus on providing information that can be effectively applied. Today being a consumer-driven market, companies require information to deal with the complex and dynamic world of choices, where relying on a soundboard firm for your decisions becomes crucial. Research N Reports specializes in industry analysis, market forecasts and as a result getting quality reports covering all verticals, whether be it gaining perspective on current market conditions or being ahead in the cutthroat global competition. Since we excel at business research to help businesses grow, we also offer to consult as an extended arm to our services which only helps us gain more insight into current trends and problems. Consequently, we keep evolving as an all-rounder provider of viable information under one roof.
(Research N Reports)
10916, Gold Point Dr,
Houston, TX, Pin – 77064,
ABBOTT EXPANDS PERIPHERAL VASCULAR OFFERINGS WITH ACQUISITION OF WALK VASCULAR, LLC
Abbott Park, III.: Abbott has recently announced that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system…
Abbott Park, III.: Abbott has recently announced that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular’s peripheral thrombectomy systems will be incorporated into Abbott’s existing endovascular product portfolio. Financial terms were not disclosed.
“The acquisition of Walk Vascular fits well into our leading vascular device offerings and further drives Abbott’s ability to provide one-of-a-kind endovascular therapy solutions to improve patient care,” said Julie Tyler, senior vice president of Abbott’s vascular business. “Walk Vascular’s technology provides physicians with tools to efficiently remove dangerous clots from blood vessels to improve patient care.”
Walk Vascular’s JETi Peripheral Thrombectomy System and next-generation JETi AIO (All In One) Peripheral Thrombectomy System are unique aspiration systems for the removal of intravascular clots, known as thrombus, that can reduce blood flow and lead to serious complications for patients. The innovative JETi systems are designed to break-up and remove clots from the peripheral vascular system while reducing the risk of dislodged clots. The systems are backed by real-world clinical experiences, and Walk is currently enrolling up to 250 patients in the United States and Europe in the JETi Registry.
Ruchika joined Medical Dialogue an Desk Editor for the Business Section in 2019. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate from Delhi University. She can be contacted at firstname.lastname@example.org Contact no. 011-43720751
ViewMind announces developer agreement with HP to help revolutionise the diagnosis and treatment of cognitive disorders
NEW YORK, Aug. 5, 2021 /PRNewswire/ — The medical device, digital health and artificial intelligence company ViewMind, today announces a new deve…
NEW YORK, Aug. 5, 2021 /PRNewswire/ — The medical device, digital health and artificial intelligence company ViewMind, today announces a new development agreement with HP Inc [HPQ]. ViewMind will use HP’s new Reverb G2 Omnicept VR Headset as part of ViewMind’s medical device solution to diagnose and monitor cognitive disorders. By collaborating with HP, ViewMind can rapidly expand, scale and secure global distribution for its award-winning breakthrough technology.
ViewMind has pioneered an affordable, reliable and accessible digital biomarker for cognitive health and will draw on biosensors within the HP Reverb G2 Omnicept VR Headset to track eye movements of patients in response to visual stimulus delivered through the headset. The biometric data recorded is sent to ViewMind’s AI trained algorithms, which enable the screening, diagnosis and monitoring of cognitive disorders.
Alzheimer’s disease pathology commences around 20 years before symptoms. By the time a medical diagnosis occurs, a lot of irreversible damage has occurred. It is therefore imperative to be able to predict accurately who will convert to Alzheimer’s and who will not convert when mild symptoms are first observed. Another area of importance is treatment impact and the ability to measure outcomes and to even screen at the very start of the disease when lifestyle changes and new drug treatments could have the greatest impact on an individual’s cognitive health longevity.
Mark Edwards, CEO ViewMind Inc, “ViewMind are delighted to be collaborating with HP to access the latest innovative HP technologies such as the new HP Reverb G2 Omnicept Edition VR Headset and to ensure ViewMind’s award-winning solution can be accessed across global markets.”
“ViewMind’s technology applies to a range of neurocognitive conditions, an exceptional and unique value proposition. The company is well-poised for massive commercialization success, guaranteeing top-class customer satisfaction and value,” Ojaswi Rana, Best Practices Research Analyst, Frost & Sullivan.
Jay Fraser, Head of XR Developer Relations, “ViewMind choosing the HP Omnicept SDK to tackle some of the major challenges in cognitive health diagnosis highlights HP’s commitment to solutions that can make a significant global and societal impact in digital health.”
ViewMind Inc provides a suite of novel digital biomarker for neurocognitive disorder diagnostics using Artificial Intelligence. ViewMind’s Digital Biomarker’s are reliable, non-invasive, affordable, accessible, and work on individuals independent of culture. To follow ViewMind on LinkedIn, click here.
SOURCE ViewMind Inc
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post.
Titan Medical Announces Appointment of Tammy Carrea as Vice President of Quality and Regulatory Affairs
TORONTO, August 02, 2021–Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the appointment of Tammy Carrea as Vice President of Quality and Regulatory Affairs.
TORONTO, August 02, 2021–(BUSINESS WIRE)–Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the appointment of Tammy Carrea as Vice President of Quality and Regulatory Affairs.
“We are delighted that Tammy has joined Titan Medical’s leadership team as we advance our Enos™ robotic single access surgery system toward human clinical studies,” said David McNally, President and Chief Executive Officer. “Her proven track record in developing and implementing clinical and regulatory strategies, obtaining medical device regulatory clearances and successfully managing FDA inspections will be invaluable assets for Titan. It is my pleasure to welcome Tammy to Titan and I look forward to working with her as we progress toward submitting our application for Investigational Device Exemption for the Enos system to the FDA.”
Ms. Carrea has more than 25 years of experience in managing quality assurance and regulatory affairs activities in the medical device industry, including robotic assisted surgery. Ms. Carrea has been responsible for global submissions and registrations for Class 1, 2, and 3 medical devices including De Novo applications. Most recently, she served as Vice President, Regulatory and Clinical Affairs and Security Officer of Translational Imaging Innovations, Inc., which produced software for ophthalmology medical imaging and cloud data management to enable AI algorithm development. Ms. Carrea holds a Bachelor of Science Degree in Materials Science and Engineering from North Carolina State University, and a Master of Science Degree in Quality and Regulatory Affairs from Temple University, with a concentration in medical devices and clinical research.
“I am thrilled to join Titan’s impressive leadership team during such a pivotal time in the company’s evolution. I look forward to applying my background and experience to help the company to realize its vision for commercializing its Enos robotic single access surgical system for the benefit of patients, while enhancing the surgical experience for surgeons and hospital staff,” said Ms. Carrea.
Curtis Jensen, Titan’s Vice President of Quality and Regulatory Affairs since April 2017, leaves the Company to pursue other opportunities in the medical device industry. “We thank Curtis for his contributions to the development program for the Enos system. Curtis commuted a long distance to Chapel Hill while the Company established a team to advance the development of the Enos system. We wish Curtis the best in his future endeavors,” said David McNally.
About Titan Medical
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company headquartered in Toronto, Ontario and with R&D facilities in Chapel Hill, North Carolina, is focused on enhancing robotic assisted surgery using innovative technology through a single access point. The Enos™ robotic single access surgical system is being developed with an ergonomic focus to provide a surgical experience that imitates real-life movements that surgeons demand and includes multi-articulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. With the Enos system, Titan intends to initially pursue gynecologic surgical indications.
Certain aspects of Titan’s robotic assisted surgical technologies and related intellectual property have been licensed to Medtronic plc, while retaining world-wide rights to commercialize the technologies for use with the Enos system.
Enos™ is a trademark of Titan Medical Inc.
For more information, visit www.titanmedicalinc.com.
This news release contains “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws, which reflect the current expectations of management of the Company’s future growth, results of operations, performance, and business prospects and opportunities. Wherever possible, words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions have been used to identify these forward-looking statements, including, without limitation, references to: the Company’s progress toward submitting an application for Investigational Device Exemption for the Enos system to the FDA; the Company’s focus on the design and development of surgical technologies for robotic single access surgery; the Enos system is being developed with dual 3D and 2D high-definition vision systems, multi-articulating instruments and an ergonomic surgeon workstation; and that Titan intends to initially pursue gynecologic surgical indications. These statements reflect management’s current beliefs and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the “Risk Factors” section of the Company’s Annual Information Form and Form 40-F for the fiscal year ended December 31, 2020 (which may be viewed at www.sedar.com and at www.sec.gov). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, the Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210802005169/en/
Vice President, Investor Relations & Corporate Communications
What Do Analysts Think Of Shell’s $9.5B Permian Asset Sale To ConocoPhillips?
Gen. Milley Termed Help Employee Assault ‘a Righteous Strike’ – It Exposes Flaws in ‘Over-the-Horizon’ Counterterror System
Shell Looks To Be Leader in SAF Production
XRP Price on a downtrend! A steep fall to $0.60 level expected
‘Crypto Networks Are Going to Be the Foundation for So Many Things,’ Says Blockchain Association’s Kristin Smith
DataRobot CEO Dan Wright coming to TC Sessions: SaaS to discuss role of data in machine learning – TechCrunch
U.S. election regulator dismisses claim that Twitter broke law by blocking story -source
U.S. to work with Big Tech, finance sector on new cybersecurity guidelines
Coinbase slammed for what users say is terrible customer service after hackers drain their accounts
Nick Davatzes, Founder Of A+E Networks, History Channel, Dies At 79
ZDNET5 months ago
New Amazon Fire HD 10 tablets bundle Microsoft 365 and a keyboard case
Ethicalmarkets6 months ago
Join Us in Challenging the Status Quo to Create a More Inclusive, Sustainable Future
Aviation8 months ago
Trapped in ice
Reuters8 months ago
Facebook oversight board overrules company on most cases in first test
Press Releases2 months ago
Connecticut comes on board as 19th legal marijuana state
Reuters8 months ago
Italy public debt to hit new post-war record in 2021 at 158.5% of GDP – source
CNBC9 months ago
Qualcomm CEO Steve Mollenkopf is retiring, current president to take over
Bioengineer8 months ago
In a tight spot